Search research articles
Contact Us
Filters
Showing results (331-340 of 400) with videos related to
Page
of 40
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 11, 2013
Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: Part I. Biology of relapse after transplantation
Ronald E Gress, Jeffrey S Miller, Minoo Battiwalla, et al.
Cytotherapy
|
February 6, 2003
Catastrophic failures of freezing bags for cellular therapy products: description, cause, and consequences
H M Khuu, H Cowley, V David-Ocampo, et al.
Journal of Medicinal Chemistry
|
May 9, 2013
Discovery of N-{4-[(3-hydroxyphenyl)-3-methylpiperazin-1-yl]methyl-2-methylpropyl}-4-phenoxybenzamide analogues as selective kappa opioid receptor antagonists
Chad M Kormos, Chunyang Jin, Juan Pablo Cueva, et al.
Nature Medicine
|
June 17, 2024
Enhancing pediatric access to cell and gene therapies
Crystal L Mackall, Catherine M Bollard, Nancy Goodman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 8, 2011
Reduced-intensity allogeneic stem cell transplantation in children and young adults with ultrahigh-risk pediatric sarcomas
Kristin Baird, Terry J Fry, Seth M Steinberg, et al.
Transfusion
|
February 14, 2004
Pediatric large-volume leukapheresis: a single institution experience with heparin versus citrate-based anticoagulant regimens
Charles D Bolan, Yu Ying Yau, Herbert C Cullis, et al.
Journal of Proteomics
|
June 11, 2008
Mass spectrometric quantification of asparagine synthetase in circulating leukemia cells from acute lymphoblastic leukemia patients
Susan E Abbatiello, Yuan-Xiang Pan, Mi Zhou, et al.
Journal of Medicinal Chemistry
|
July 24, 2018
Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3 R)- N-[1 R)-1-(Cyclohexylmethyl)-2-methylpropyl]-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (CDTic)
Chad M Kormos, Pauline W Ondachi, Scott P Runyon, et al.
Pediatric Blood & Cancer
|
May 26, 2018
Myeloid lineage switch following chimeric antigen receptor T-cell therapy in a patient with TCF3-ZNF384 fusion-positive B-lymphoblastic leukemia
Matthew J Oberley, Paul S Gaynon, Deepa Bhojwani, et al.
Journal of Medicinal Chemistry
|
August 18, 2018
Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3 R)-7-Hydroxy- N-[(1 S)-2-methyl-1-(piperidin-1-ylmethyl)propyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (PDTic)
Pauline W Ondachi, Chad M Kormos, Scott P Runyon, et al.
Page
of 40
Search research articles
Search
Showing results (331-340 of 400) with videos related to
Sort By:
Page
of 40
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 11, 2013
Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: Part I. Biology of relapse after transplantation
Ronald E Gress, Jeffrey S Miller, Minoo Battiwalla, et al.
Cytotherapy
|
February 6, 2003
Catastrophic failures of freezing bags for cellular therapy products: description, cause, and consequences
H M Khuu, H Cowley, V David-Ocampo, et al.
Journal of Medicinal Chemistry
|
May 9, 2013
Discovery of N-{4-[(3-hydroxyphenyl)-3-methylpiperazin-1-yl]methyl-2-methylpropyl}-4-phenoxybenzamide analogues as selective kappa opioid receptor antagonists
Chad M Kormos, Chunyang Jin, Juan Pablo Cueva, et al.
Nature Medicine
|
June 17, 2024
Enhancing pediatric access to cell and gene therapies
Crystal L Mackall, Catherine M Bollard, Nancy Goodman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 8, 2011
Reduced-intensity allogeneic stem cell transplantation in children and young adults with ultrahigh-risk pediatric sarcomas
Kristin Baird, Terry J Fry, Seth M Steinberg, et al.
Transfusion
|
February 14, 2004
Pediatric large-volume leukapheresis: a single institution experience with heparin versus citrate-based anticoagulant regimens
Charles D Bolan, Yu Ying Yau, Herbert C Cullis, et al.
Journal of Proteomics
|
June 11, 2008
Mass spectrometric quantification of asparagine synthetase in circulating leukemia cells from acute lymphoblastic leukemia patients
Susan E Abbatiello, Yuan-Xiang Pan, Mi Zhou, et al.
Journal of Medicinal Chemistry
|
July 24, 2018
Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3 R)- N-[1 R)-1-(Cyclohexylmethyl)-2-methylpropyl]-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (CDTic)
Chad M Kormos, Pauline W Ondachi, Scott P Runyon, et al.
Pediatric Blood & Cancer
|
May 26, 2018
Myeloid lineage switch following chimeric antigen receptor T-cell therapy in a patient with TCF3-ZNF384 fusion-positive B-lymphoblastic leukemia
Matthew J Oberley, Paul S Gaynon, Deepa Bhojwani, et al.
Journal of Medicinal Chemistry
|
August 18, 2018
Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3 R)-7-Hydroxy- N-[(1 S)-2-methyl-1-(piperidin-1-ylmethyl)propyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (PDTic)
Pauline W Ondachi, Chad M Kormos, Scott P Runyon, et al.
Page
of 40